Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03312114
Title Anti—PD-L1 and SAbR for Ovarian Cancer
Recruitment Terminated
Gender female
Phase Phase II
Variant Requirements No
Sponsors University of Texas Southwestern Medical Center
Indications

ovary epithelial cancer

fallopian tube cancer

peritoneum cancer

Therapies

Avelumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.